Trial intelligence / Profile preview

VASO-SHOCK

NCT06072508Completed

Sponsor
CHU Amiens-Picardie
Start
Jul 2023
Primary completion
Mar 2025
Countries
1
01

Overview

Single-arm trial, sponsored by CHU Amiens-Picardie. Primary endpoints: Correlation between vasorin concentration at day 0 and mortality rate and Correlation between vasorin concentration at day 3 and mortality rate. Started Jul 2023; status: completed.

Beyond the preview

Go deeper on NCT06072508.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06072508.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call